Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia

PURPOSE: To investigate the effects of topical and perilesional interferon alpha-2b as primary treatment for ocular surface squamous neoplasia (OSSN). METHODS: In this prospective interventional case series, topical interferon alpha-2b (3 MIU/mL) was used as the initial treatment of OSSN, with peril...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaffari, Reza, Barijani, Sahar, Alivand, Arash, Latifi, Golshan, Ghassemi, Hamed, Zarei-Ghanavati, Mehran, Djalilian, Ali R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579786/
https://www.ncbi.nlm.nih.gov/pubmed/34765812
http://dx.doi.org/10.4103/2452-2325.329089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579786/
https://www.ncbi.nlm.nih.gov/pubmed/34765812
http://dx.doi.org/10.4103/2452-2325.329089

Ejemplares similares